Asia Real Estate News Tracker, Asia Real Estate Tracker

Asia Real Estate Tracker

Asia Real Estate News Tracker

Tracking developments across Asia's regional real estate markets

Thematic (Sector/Industry)

<ul>
<li>Rava has successfully acquired Peninsula Private Hospital from Australian Unity for a total of $208 million.</li>
<li>Blackstone's Horizon has reported a significant 36% increase in EBITDA and a notable reduction in losses post-IPO in India.</li>
<li>NFD Korea has begun construction on a substantial 300MW AI data center campus located in Danjin, South Korea.</li>
</ul>


Rava has successfully acquired Peninsula Private Hospital from Australian Unity for a total of $208 million.
Blackstone's Horizon has reported a significant 36% increase in EBITDA and a notable reduction in losses post-IPO in India.
NFD Korea has begun construction on a substantial 300MW AI data center campus located in Danjin, South Korea.


Asia Real Estate Tracker (15-Sep-2026): Rava buys Peninsula Private Hospital for $208M.

Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

Asia Pac ECM and Index Rebal

Asia Pac IPO & Placement Research, China Biotech

Shenton Research

Shenton Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Quantitative Analysis

<ul>
<li>We analyzed the changes in short interest of ASX Stocks as of Sep 11th (reported today). The aggregated short interest was USD49.8bn.</li>
<li>We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.</li>
<li>We highlight short interest changes in Light &amp; Wonder, Northern Star Resources, Predictive Discovery, Nextdc, Sigma Pharmaceuticals.</li>
</ul>


We analyzed the changes in short interest of ASX Stocks as of Sep 11th (reported today). The aggregated short interest was USD49.8bn.
We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.
We highlight short interest changes in Light &amp; Wonder, Northern Star Resources, Predictive Discovery, Nextdc, Sigma Pharmaceuticals.


ASX Short Interest Weekly (Sep 11th): Light & Wonder, Northern Star Resources, Predictive Discovery

Global Healthcare Analyst

Tina Banerjee

<ul>
<li>Ono Pharmaceutical received FDA approval for Romvimza for the treatment of symptomatic tenosynovial giant cell tumor. Shionogi obtains domestic approval for digital therapeutic app, Endeavorride for ADHD.</li>
<li>Samsung Biologics received FDA and European Commission approval for Prolia biosimilar. Celltrion received European approval for Prolia and Eylea biosimilars. Cosette Pharmaceuticals is acquiring Mayne Pharma for A$7.40 per share.</li>
<li>CSPC Pharmaceutical granted an exclusive license to Radiance Biopharma to develop and commercialize antibody drug conjugates SYS6005 in selected geographies. Cipla received FDA approval for anti-cancer drug Nilotinib capsules.</li>
</ul>


Ono Pharmaceutical received FDA approval for Romvimza for the treatment of symptomatic tenosynovial giant cell tumor. Shionogi obtains domestic approval for digital therapeutic app, Endeavorride for ADHD.
Samsung Biologics received FDA and European Commission approval for Prolia biosimilar. Celltrion received European approval for Prolia and Eylea biosimilars. Cosette Pharmaceuticals is acquiring Mayne Pharma for A$7.40 per share.
CSPC Pharmaceutical granted an exclusive license to Radiance Biopharma to develop and commercialize antibody drug conjugates SYS6005 in selected geographies. Cipla received FDA approval for anti-cancer drug Nilotinib capsules.


APAC Healthcare Weekly (Feb 23)- Ono Pharma, Shionogi, Samsung Biologics, Celltrion, CSPC, Mayne

European Event-Driven Analyst

Jesus Rodriguez Aguilar

Event-Driven

<ul>
<li>Toscafund’s 250p proposal is now a recommended, fully financed Scheme, backed by Three Hills and Ares, with irrevocables covering 42.7% of Scheme Shares.</li>
<li>Even at 100% turnout, Bidco needs support from only 56.4% of remaining uncommitted Scheme Shares. We assign 90% completion probability.</li>
<li>More than 60 potential buyers were contacted over eight months. No higher executable proposal emerged, leaving limited scope for a topping bid.</li>
</ul>


Toscafund’s 250p proposal is now a recommended, fully financed Scheme, backed by Three Hills and Ares, with irrevocables covering 42.7% of Scheme Shares.
Even at 100% turnout, Bidco needs support from only 56.4% of remaining uncommitted Scheme Shares. We assign 90% completion probability.
More than 60 potential buyers were contacted over eight months. No higher executable proposal emerged, leaving limited scope for a topping bid.


Spire Healthcare: 250p, This Time With a Deal

<ul>
<li>We analyzed the changes in short interest of ASX Stocks as of Aug 28th (reported today). The aggregated short interest was USD50.8bn.</li>
<li>We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.</li>
<li>We highlight short interest changes in Steadfast, Brambles, Worley, Transurban, Charter Hall.</li>
</ul>


We analyzed the changes in short interest of ASX Stocks as of Aug 28th (reported today). The aggregated short interest was USD50.8bn.
We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.
We highlight short interest changes in Steadfast, Brambles, Worley, Transurban, Charter Hall.


ASX Short Interest Weekly (Aug 28th): Steadfast, Brambles, Worley, Transurban, Charter Hall

Australia

Ramsay Health Care Ltd. provides health care services. The Company offers private hospital services, including, rehabilitation, psychiatric care, day, and complex surgery. Ramsay Health Care owns, operates, and manages health care facilities throughout Australia, Indonesia, and Europe.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Ramsay Health Care (RHC AU)

Asia Real Estate Tracker (15-Sep-2026): Rava buys Peninsula Private Hospital for $208M.

Rava acquired Peninsula Private Hospital for $208M, Blackstone's Horizon reported a 36% EBITDA increase, and NFD Korea began a 300MW data center in...

Asia Real Estate Tracker

ASX Short Interest Weekly (Sep 11th): Light & Wonder, Northern Star Resources, Predictive Discovery

We analyzed ASX short interest report for the past week and highlight short interest changes in Light & Wonder, Northern Star Resources, Predictive...

Ke Yan, CFA, FRM

APAC Healthcare Weekly (Feb 23)- Ono Pharma, Shionogi, Samsung Biologics, Celltrion, CSPC, Mayne

APAC healthcare companies continued to get approvals for new products and initiates clinical trials. The companies continued with acquisitions and...

Tina Banerjee

Spire Healthcare: 250p, This Time With a Deal

Spire’s long-running sale process has finally produced a firm 250p deal. With Friday’s close predating the Rule 2.7, Monday’s open should be worth...

Jesus Rodriguez Aguilar

ASX Short Interest Weekly (Aug 28th): Steadfast, Brambles, Worley, Transurban, Charter Hall

We analyzed ASX short interest report for the past week and highlight short interest changes in Steadfast, Brambles, Worley, Transurban, Charter Hall.

Ke Yan, CFA, FRM

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)